— Know what they know.
Not Investment Advice

MNKD NASDAQ

MannKind Corporation
1W: +2.8% 1M: +20.8% 3M: -40.2% YTD: -40.9% 1Y: -24.1% 3Y: -24.6% 5Y: -23.2%
$3.38
+0.07 (+2.11%)
 
Weekly Expected Move ±14.2%
$2 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 61 · $1.0B mcap · 304M float · 2.26% daily turnover · Short 58% of daily vol

Balance Sheet Trends

Total Assets
$792M +101.1% ▲
5Y CAGR: +48.8%
Total Liabilities
$843M +78.4% ▲
5Y CAGR: +23.9%
Shareholders Equity
-$51M +35.3% ▲
Cash & Investments
$171M -13.1% ▼
5Y CAGR: +20.7%
Total Debt
$473M +892.5% ▲
5Y CAGR: +30.8%
Net Debt
$399M +29266.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$124M$70M$238M$46M$75M
Short-Term Investments$80M$101M$57M$151M$96M
Cash & ST Investments$204M$171M$295M$197M$171M
Net Receivables$5M$17M$15M$12M$38M
Inventory$7M$22M$29M$28M$35M
Other Current Assets$0$25M$35M$31M$47M
Total Current Assets$219M$235M$373M$268M$292M
Property, Plant & Equip.$37M$45M$84M$85M$82M
Goodwill & Intangibles$0$4M$3M$7M$73M
Long-Term Investments$57M$2M$7M$5M$5M
Other Non-Current Assets$8M$10M$7M$27M$341M
Total Non-Current Assets$102M$60M$102M$126M$501M
Total Assets$321M$295M$475M$394M$792M
— Liabilities —
Accounts Payable$7M$11M$10M$7M$9M
Short-Term Debt$7M$10M$20M$0$49M
Deferred Revenue$827K$2M$9M$12M$15M
Other Current Liabilities$10M$16M$31M$30M$97M
Total Current Liabilities$48M$67M$104M$82M$171M
Long-Term Debt$281M$273M$249M$36M$320M
Other Non-Current Liab.$175M$162M$295M$292M$208M
Total Non-Current Liabilities$482M$479M$617M$391M$672M
Total Liabilities$531M$546M$721M$473M$843M
— Equity —
Common Stock$3M$3M$3M$3M$3M
Retained Earnings-$3.1B-$3.2B-$3.2B-$3.2B-$3.2B
Accumulated OCI$0$0$0$1M$115K
Total Stockholders Equity-$209M-$251M-$246M-$79M-$51M
Total Liabilities & Equity$321M$295M$475M$394M$792M
— Key Metrics —
Total Debt$289M$288M$273M$48M$473M
Net Debt$165M$219M$34M$1M$399M
Total Investments$137M$103M$64M$156M$101M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms